Aerami Therapeutics CEO Lisa Yañez passes away, chair to lead heart disease biotech
Aerami Therapeutics, which is working on an inhaled therapy for hypertension, said Friday morning its CEO Lisa Yañez passed away earlier this week.
Yañez, 50 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.